It is well known that fear of recurrence is a major issue in the cancer community, but can genetic test results outlining risk impact those feelings?
It is well known that fear of recurrence is a major issue in the cancer community, but can genetic test results outlining risk impact those feelings?
For this episode of “The Vitals,” we spoke with Maurade Gormley, CPNP, RN, assistant professor and post-doctoral fellow at the NYU Rory Myers College of Nursing. Her recent research analyzed how Oncotype DX genomic test results may increase fear of recurrence in breast cancer survivors.
Making an Impact on Disparities in Radiotherapy for Breast Cancer
March 11th 2024Cancer teams, including oncology nurses, can make conscious choices to potentially alleviate the disparities that persist in hypofractionation, toxicity, and cardiac doses in radiotherapy for Black and Asian patients with breast cancer.